{
  "id": 10685445,
  "title": "MPP Signs Multiple Regional Agreements to Expand Access to Flu Antiviral Medicine",
  "url": "https://urgent.news/2026/09/29/mpp-signs-multiple-regional-agreements-to-expand-access-to-flu",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-29T11:38:38.000Z",
  "source": {
    "name": "Health Policy Watch",
    "slug": "health-policy-watch",
    "url": "https://healthpolicy-watch.news/mpp-signs-multiple-regional-agreements-to-expand-access-to-flu-antiviral-medicine/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Medicines Patent Pool (MPP) has signed sublicense agreements with 11 manufacturers across multiple regions to expand access to generic baloxavir marboxil, a single-dose antiviral treatment for influenza that was originally developed by Swiss pharmaceutical company Roche. The announcement, made the night before last Friday’s UN High-Level Meeting on Pandemic Prevention, Preparedness and…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}